7 Amendments of Kriton ARSENIS related to 2012/2066(INI)
Amendment 15 #
Motion for a resolution
Recital A
Recital A
A. whereas hormone-related disorders and illnesses in humans have increased over the last 20 years, including impaired sperm quality, early onset of puberty, increased incidence of deformed sexual organs, increased incidence of certain forms of cancer and many cases of metabolic illnesses as well as neurological disorders and neurodegenerative diseases;
Amendment 90 #
Motion for a resolution
Paragraph 8
Paragraph 8
8. Calls on the Commission to introduce in all relevant EU legislation appropriate testing requirements for the identification of substances with endocrine-disrupting properties; considers that the validated and internationally recognised testing methods that have been developed in (for example) the OECD must be implemented; notes that the OECD programme of testing methods covers sex hormones and thyroid hormones as well as steroidogenesis; points out, on the other hand, that there are no tests for other areas of the endocrine system, e.g. insulin and growth hormones; considers that testing methods and guidance documents should be developed so as to take better account of endocrine disruptors, possible low-dose effects, combination effects and non- monotonic dose-response relationships;
Amendment 106 #
Motion for a resolution
Paragraph 10
Paragraph 10
10. Calls on the Commission, in its review of EU strategy on endocrine disruptors, to place greater emphasis on the precautionary principle and work towards reducing human and wildlife exposure to endocrine disruptors;
Amendment 120 #
Motion for a resolution
Paragraph 12 a (new)
Paragraph 12 a (new)
12 a. Calls on the Commission to review Directive 2009/48/EC in order to effectively protect children from their exposure to endocrine disrupting chemicals;
Amendment 127 #
Motion for a resolution
Paragraph 13
Paragraph 13
13. Takes the view that endocrine disruptors should be regarded as Substances of Very High Concern within the meaning of the Reach Regulation and as Priority Hazardous Substances within the meaning of the Water Framework Directive; considers, therefore, that endocrine disruptors should be subject to authorisation or restriction with a view to substitution;
Amendment 142 #
Motion for a resolution
Paragraph 15 a (new)
Paragraph 15 a (new)
15 a. Calls on the Commission to develop in vitro and in silico methodologies in order to minimise animal testing for endocrine disruptors screening;
Amendment 148 #
Motion for a resolution
Paragraph 16
Paragraph 16
16. Calls on the Commission to include all relevant stakeholders in cooperation seeking to adopt the necessary legislative changes to improve protection of human health and the environment from hormone-disrupting chemicals;